fda drug shortages tirzepatide zepbound shortage status 2025 confirms is still over, gives compounders a grace period Tirzepatide Shortage Ends - American

In correlation with this, IQVIA data reported a lack of growth between weeks 17 and 20 and even a dip in week 21 (see graph below)

Branded Medications Only Klinic dedicates itself to prescribing only FDA-approved and branded medications such as Wegovy and Foundayo, ensuring quality you can trust

Cost and accessibility represent additional barriers

Vooral nieuwe gebruikers van middelen als Ozempic zorgen voor een kostenstijging

The applicability to women on GLP-1 therapy specifically is not yet studied

Most major insurers cover semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro, Zepbound) only after step-therapy protocolsmeaning you must try and fail cheaper alternatives first